Published • loading... • Updated
EDX Medical Group Deploys Rapid Pneumonia Test At Addenbrooke’s ICU
Summary by DirectorsTalk Interviews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
EDX Medical Group Deploys Rapid Pneumonia Test At Addenbrooke’s ICU
EDX Medical Group plc (AQSE:EDX), which develops innovative digital diagnostic products and services for major diseases, has completed the development and technical validation of a pioneering rapid pneumonia test for critically ill patients that is now being deployed successfully in NHS clinical practice. The Ventilator-Acquired Pneumonia test, or ‘VAP’ test, enables rapid and informed changes to antibiotic prescribing and enhancement of clinica…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
